
    
      The study is a multicentric, retrospective clinical study based on the hospital. The target
      number of cases are X patients who are eligible for breast cancer after radical mastectomy.
      To collect the clinicopathological data and treatment data of the breast cancer patients and
      do the follow-up visit of all the patients who are included in the study.
    
  